[Preprint] Estudo RECOVERY mostra que aspirina não melhora a sobrevida de pacientes hospitalizados com COVID-19.

Comunicado de imprensa: RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19 – University of Oxford

Estudo original: Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv

Comentário no Twitter (fio – clique para saber mais)

RECOVERY Pre-print: Aspirin

14,892 patients randomised to aspirin vs. usual care
– no impact on all-cause mortality (17% vs. 17%)
– similar results in all pre-specified subgroupshttps://t.co/ay5Xg4GBVD pic.twitter.com/aNJ09RTTOa

— Martin Landray (@MartinLandray) June 8, 2021